Pharma faces regulations and stringent rules for transparency, but the payoff is drugs that can get to market faster and ...

Johnson & Johnson’s $14.6 billion buyout of Intra-Cellular in the first mo | Of the top 10 biopharma M&A deals of 2025, six ...

While Novartis secured the biggest deal of the fourth quarter, a handful of riveting tales emerged from the bottom of the M&A ...

Semaglutide patent expiries in India, Canada, and Brazil are poised to unlock over Rs 50 billion in revenue for generic ...

It’s been another whirlwind year in the world of pharma marketing. | Updates on DTC advertising and DTP programs, as well as special reports, event coverage and, of course, news bulletins from the ...

Check out a month-by-month breakdown of the major events affecting the pharma and medical marketing industries in 2025.

Axonal.AI distinguishes itself from the current wave of generative AI chatbots by positioning itself as an enterprise-native operating layer. While standard LLMs often hallucinate or prioritize ...

Asahi Kasei Pharma Corporation has announced plans to relocate its R&D hub from Izunokuni City, Shizuoka Prefecture (Ohito) ...

Shares in Ironwood Pharmaceuticals ($IRWD), which creates and sells medicines for people with severe stomach and digestive ...

Shionogi plans a $2.5B acquisition of a Jersey City pharma holding ALS drug Radicava rights, expanding its U.S. rare disease ...

Dec 24 (Reuters) - Shares of Agios ‌Pharmaceuticals ​jumped nearly 12% premarket ‌on Wednesday after the U.S. Food ​and Drug Administration approved the expanded use of its drug ‍for the treatment of ...